IMDX
Insight Molecular Diagnostics
IMDX
IMDX
30 hedge funds and large institutions have $49.2M invested in Insight Molecular Diagnostics in 2025 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 9 increasing their positions, 6 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
6.29% more ownership
Funds ownership: 49.97% → 56.27% (+6.3%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
30
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$15.8M | |
| 2 | +$6.26M | |
| 3 | +$896K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$149K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$137K |
Top Sellers
| 1 | -$31.5K | |
| 2 | -$31K | |
| 3 | -$26K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$9.64K |
| 5 |
DC
Defender Capital
Charlotte,
North Carolina
|
-$7.72K |
